In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Pharmaceutical Biotechnology

• Publication date

  2008-03-31

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.2174/138920108783955218PMID 18393867
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PocketDepth: a new depth based algorithm for identification of ligand binding sites in proteins.

  2008cited by this paper
• Novel paradigms for drug discovery: computational multitarget screening.

  2008cited by this paper
• Frog: a FRee Online druG 3D conformation generator

  2007cited by this paper
• A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application

  2007cited by this paper
• Docking Ligands into Flexible and Solvated Macromolecules, 1. Development and Validation of FITTED 1.0

  2007cited by this paper
• Structure-based maximal affinity model predicts small-molecule druggability

  2007cited by this paper
• FastContact: a free energy scoring tool for protein–protein complex structures

  2007cited by this paper
• Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates.

  2007cited by this paper
• Scaffolds for blocking protein-protein interactions.

  2007cited by this paper
• GlamDock: Development and Validation of a New Docking Tool on Several Thousand Protein-Ligand Complexes

  2007cited by this paper
• Design of protein–membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V

  2007cited by this paper
• New and Original pKa Prediction Method Using Grid Molecular Interaction Fields

  2007cited by this paper
• Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

  2007cited by this paper
• siteFiNDER|3D: a web-based tool for predicting the location of functional sites in proteins

  2007cited by this paper
• Protein-protein interaction inhibitors: small molecules from screening techniques.

  2007cited by this paper
• DOCKGROUND system of databases for protein recognition studies: Unbound structures for docking

  2007cited by this paper
• Prediction and scoring of docking poses with pyDock

  2007cited by this paper
• 3D-partner: a web server to infer interacting partners and binding models

  2007cited by this paper
• Transient pockets on protein surfaces involved in protein-protein interaction.

  2007cited by this paper
• Hot spots—A review of the protein–protein interface determinant amino‐acid residues

  2007cited by this paper
• Importance of molecular computer modeling in anticancer drug development.

  2007cited by this paper
• Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility

  2007cited by this paper
• Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737.

  2007cited by this paper
• InSite: a computational method for identifying protein-protein interaction binding sites on a proteome-wide scale

  2007cited by this paper
• Human protein-protein interaction networks and the value for drug discovery.

  2007cited by this paper
• Computational identification of inhibitors of protein-protein interactions.

  2007cited by this paper
• Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem

  2007cited by this paper
• Ligand docking and structure-based virtual screening in drug discovery.

  2007cited by this paper
• Patch Finder Plus (PFplus): A web server for extracting and displaying positive electrostatic patches on protein surfaces

  2007cited by this paper
• Strategies to search and design stabilizers of protein–protein interactions: A feasibility study

  2007cited by this paper
• Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness.

  2007cited by this paper
• Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.

  2007cited by this paper
• Towards drugs targeting multiple proteins in a systems biology approach.

  2007cited by this paper
• Disruption of the Keap1-containing ubiquitination complex as an antioxidant therapy.

  2007cited by this paper
• Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methods.

  2007cited by this paper
• Peak selection from MALDI-TOF mass spectra using ant colony optimization

  2007cited by this paper
• Impact of ligand protonation on virtual screening against beta-secretase (BACE1).

  2007cited by this paper
• FLIPDock: Docking flexible ligands into flexible receptors

  2007cited by this paper
• The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics

  2007cited by this paper
• PocketPicker: analysis of ligand binding-sites with shape descriptors

  2007cited by this paper
• PIER: Protein interface recognition for structural proteomics

  2007cited by this paper
• Virtual screening strategies in drug discovery.

  2007cited by this paper
• Measuring CAMD Technique Performance, 2. How "Druglike" Are Drugs? Implications of Random Test Set Selection Exemplified Using Druglikeness Classification Models

  2007cited by this paper
• Calculation of protein-ligand binding affinities.

  2007cited by this paper
• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

  2007cited by this paper
• What is the relationship between the global structures of apo and holo proteins?

  2007cited by this paper
• New Method for Fast and Accurate Binding‐site Identification and Analysis

  2007cited by this paper
• Evaluation of the utility of homology models in high throughput docking

  2007cited by this paper
• Small-angle X-ray scattering from RNA, proteins, and protein complexes.

  2007cited by this paper
• PIC: Protein Interactions Calculator

  2007cited by this paper
• Small molecule protein-protein inhibitors for the p53-MDM2 interaction.

  2007cited by this paper
• Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search

  2007cited by this paper
• Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective.

  2007cited by this paper
• Physics-based methods for studying protein-ligand interactions.

  2007cited by this paper
• HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets

  2007cited by this paper
• Overcoming the Inadequacies or Limitations of Experimental Structures as Drug Targets by Using Computational Modeling Tools and Molecular Dynamics Simulations

  2007cited by this paper
• The role of quantum mechanics in structure-based drug design.

  2007cited by this paper
• Natural products as sources of new drugs over the last 25 years.

  2007cited by this paper
• Small molecule inhibitors of the XIAP protein-protein interaction.

  2007cited by this paper
• Mapping protein-protein interactions by mass spectrometry.

  2006cited by this paper
• Assessing the Scaffold Diversity of Screening Libraries

  2006cited by this paper
• Chemoproteomics-driven drug discovery: addressing high attrition rates.

  2006cited by this paper
• Between a rock and a hard place?

  2006cited by this paper
• SHARP2: protein-protein interaction predictions using patch analysis

  2006cited by this paper
• A Formylated Hexapeptide Ligand Mimics the Ability of Wnt-5a to Impair Migration of Human Breast Epithelial Cells*

  2006cited by this paper
• High-resolution protein-protein docking.

  2006cited by this paper
• Flexible protein-protein docking.

  2006cited by this paper
• Virtual ligand screening: strategies, perspectives and limitations

  2006cited by this paper
• Elucidation of Characteristic Structural Features of Ligand Binding Sites of Protein Kinases: A Neural Network Approach

  2006cited by this paper
• Deconstructing fragment-based inhibitor discovery

  2006cited by this paper
• Peptide aptamers as guides for small-molecule drug discovery.

  2006cited by this paper
• Similarity based virtual screening: a tool for targeted library design.

  2006cited by this paper
• From the Similarity Analysis of Protein Cavities to the Functional Classification of Protein Families Using Cavbase

  2006cited by this paper
• Collection and preparation of molecular databases for virtual screening

  2006cited by this paper
• LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation

  2006cited by this paper
• Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).

  2006cited by this paper
• 3D Complex: A Structural Classification of Protein Complexes

  2006cited by this paper
• Targeting protein-protein interactions with small molecules: challenges and perspectives for computational binding epitope detection and ligand finding.

  2006cited by this paper
• PSI‐DOCK: Towards highly efficient and accurate flexible ligand docking

  2006cited by this paper
• Methods for the prediction of protein-ligand binding sites for structure-based drug design and virtual ligand screening.

  2006cited by this paper
• A comparative study of available software for high‐accuracy homology modeling: From sequence alignments to structural models

  2006cited by this paper
• Targeting XIAP for the treatment of malignancy

  2006cited by this paper
• Consensus scoring for protein-ligand interactions.

  2006cited by this paper
• Structure-based development of target-specific compound libraries.

  2006cited by this paper
• Characterization of protein-ligand interaction sites using experimental and computational methods.

  2006cited by this paper
• On scaffolds and hopping in medicinal chemistry.

  2006cited by this paper
• Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units*

  2006cited by this paper
• FAF-Drugs: free ADME/tox filtering of compound collections

  2006cited by this paper
• Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers

  2006cited by this paper
• GRAMM-X public web server for protein–protein docking

  2006cited by this paper
• PROTCOM: searchable database of protein complexes enhanced with domain–domain structures

  2006cited by this paper
• Obtaining and screening compound collections: a user's guide and a call to chemists.

  2006cited by this paper
• PIPER: An FFT‐based protein docking program with pairwise potentials

  2006cited by this paper
• Efficient restraints for protein-protein docking by comparison of observed amino acid substitution patterns with those predicted from local environment.

  2006cited by this paper
• Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.

  2006cited by this paper
• Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening

  2006cited by this paper
• Chemogenomics: structuring the drug discovery process to gene families.

  2006cited by this paper
• Physics-Based Scoring of Protein-Ligand Complexes: Enrichment of Known Inhibitors in Large-Scale Virtual Screening

  2006cited by this paper
• Receptor-based computational screening of compound databases: the main docking-scoring engines.

  2006cited by this paper
• High-throughput structural characterisation of therapeutic protein targets

  2006cited by this paper

• Using network toxicology and molecular docking to identify core targets and pathways underlying tacrolimus-induced tremor in organ transplant recipients

  2025cites this paper
• AI-Driven Protein Discovery: Bridging Computational Innovation and Therapeutic Advancements

  2025cites this paper
• Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification

  2023cites this paper
• Exploration of the Potential Mechanism of Yujin Powder treating Dampness-heat Diarrhea by Integrating UPLC-MS/MS and Network Pharmacology Prediction.

  2023cites this paper
• Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema

  2023cites this paper
• Antimicrobial peptides with cell-penetrating activity as prophylactic and treatment drugs

  2022cites this paper
• Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies

  2022cites this paper
• Exploring the potential mechanism of Fritiliariae Irrhosae Bulbus on ischemic stroke based on network pharmacology and experimental validation

  2022cites this paper
• Exploring the Mechanism of Wu Ling San plus Flavor for the Treatment of Diabetic Macular Edema Based on Network Pharmacology and Molecular Docking Techniques

  2022cites this paper
• Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds

  2022cites this paper
• Residue-based pharmacophore approaches to study protein-protein interactions.

  2021cites this paper
• Molecular docking analysis of two bioactive molecules KLUF10 and KLUF13 isolated from the marine bacteria Micrococcus sp. OUS9 with TNF alpha

  2021cites this paper
• DDDT_A_319786 3255..3276

  2021cites this paper
• Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis

  2021cites this paper
• Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs

  2020cites this paper
• Understanding the Targeting Mechanisms of Multi-Specific Biologics in Immunotherapy with Multiscale Modeling

  2020cites this paper
• Structure based design of inhibitory peptides targeting ornithine decarboxylase dimeric interface and in vitro validation in human retinoblastoma Y79 cells

  2020cites this paper
• PROTEINATOR: Web-UI exploring repurposing hypotheses of PROTEIN InhibiTORs based on protein interactions

  2019cites this paper
• Towards the discovery of novel anti-Influenza agents using a reverse virtual fragment screening approach

  2019cites this paper
• In Silico Target Druggability Assessment: From Structural to Systemic Approaches.

  2019cites this paper
• Development of R7BP inhibitors through cross-linking coupled mass spectrometry and integrated modeling

  2019cites this paper
• Protein-Protein Interactions in Candida albicans

  2019cites this paper
• Overview of Protein-Protein Interactions and Small-Molecule Inhibitors Under Clinical Development

  2018cites this paper
• Advances in Human-Protein Interaction - Interactive and Immersive Molecular Simulations

  2017cites this paper
• In Silico Approaches Assisting the Rational Design of Low Molecular Weight Protein–Protein Interaction Modulators

  2015cites this paper
• The virtual heart as a platform for screening drug cardiotoxicity

  2015cites this paper
• State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.

  2015cites this paper
• In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.

  2015cites this paper
• Drug-Like Protein–Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology

  2014cites this paper
• Oncogenic protein interfaces: small molecules, big challenges

  2014cites this paper
• Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.

  2014cites this paper
• Structure-based design of small-molecule protein – protein interaction modulators : the story

  2014cites this paper
• Rational Design of Small-Molecule Stabilizers of Spermine Synthase Dimer by Virtual Screening and Free Energy-Based Approach

  2014cites this paper
• Protein-protein interface analysis and hot spots identification for chemical ligand design.

  2014cites this paper
• Structure-based design of small-molecule protein-protein interaction modulators: the story so far.

  2014cites this paper
• Computational analysis of protein-protein interfaces involving an alpha helix: insights for terphenyl–like molecules binding

  2013cites this paper
• Computational Analysis of Ligand-Binding Pockets

  2013cites this paper
• Structure-based target druggability assessment.

  2013cites this paper
• Structural systems pharmacology: the role of 3D structures in next-generation drug development.

  2013cites this paper
• AMMOS software: method and application.

  2012cites this paper
• Advances in Human-Protein Interaction - Interactive and Immersive Molecular Simulations

  2012cites this paper
• Exploring NMR ensembles of calcium binding proteins: Perspectives to design inhibitors of protein-protein interactions

  2011cites this paper
• Tyrosine Kinase Syk Non-Enzymatic Inhibitors and Potential Anti-Allergic Drug-Like Compounds Discovered by Virtual and In Vitro Screening

  2011cites this paper
• Proteome-wide prediction of overlapping small molecule and protein binding sites using structure.

  2011cites this paper
• Modulators of protein-protein interactions: novel approaches in targeting protein kinases and other pharmaceutically relevant biomolecules.

  2011cites this paper
• Atomistic models for free energy evaluation of drug binding to membrane proteins.

  2011cites this paper
• Targeting the proangiogenic VEGF-VEGFR protein-protein interface with drug-like compounds by in silico and in vitro screening.

  2011cites this paper
• Assessing drug transport across the human placental barrier: from in vivo and in vitro measurements to the ex vivo perfusion method and in silico techniques.

  2011cites this paper
• Target‐Based Virtual Screening to Address Protein–Protein Interfaces

  2011cites this paper
• Predictive bioinformatic methods for analyzing genes and proteins

  2011cites this paper
• Receptor Flexibility in Ligand Docking and Virtual Screening

  2011cites this paper
• In silico studies of blood coagulation proteins: from mosaic proteases to nonenzymatic cofactor inhibitors.

  2010cites this paper
• Enhancements of screening collections to address areas of unmet medical need: an industry perspective.

  2010cites this paper
• Evaluations of the Absolute and Relative Free Energies for Antidepressant Binding to the Amino Acid Membrane Transporter LeuT with Free Energy Simulations.

  2010cites this paper
• Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods

  2010cites this paper
• Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.

  2010cites this paper
• Rationalizing the chemical space of protein-protein interaction inhibitors.

  2010cites this paper
• Multisensory VR interaction for protein-docking in the CoRSAIRe project

  2009cites this paper
• Docking de protéines en réalité virtuelle Une approche hybride et multimodale

  2009cites this paper
• Fpocket: An open source platform for ligand pocket detection

  2009cites this paper
• Modeling effects of human single nucleotide polymorphisms on protein-protein interactions.

  2009cites this paper
• Computational design and analysis of binding pockets at protein-protein interaction interfaces

  2009cites this paper
• Protein structure prediction in structure-based ligand design and virtual screening.

  2009cites this paper
• A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.

  2009cites this paper
• Virtual screening of chemical libraries for drug discovery

  2008cites this paper
• Predicting Molecular Interactions in Structural Proteomics

  2008cites this paper
• Screening Outside the Catalytic Site: Inhibition of Macromolecular Inter-actions Through Structure-Based Virtual Ligand Screening Experiments

  2008cites this paper
• Advances and Applications in Bioinformatics and Chemistry Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Computer Applications for Prediction of Protein–protein Interactions and Rational Drug Design

  year unknowncites this paper
• Open Access book publisher

  year unknowncites this paper